CNW Share Price Performance
€0
0.00 (0.00%)
Price €0
Share Pricen/a
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CNW Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
co.don AG Key Details
Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
- -0.53
- 80.89%
- -143.55%
- 64.1%
About CNW
- Founded
- 1993
- Employees
- 134
- CEO
- WebsiteView website
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
